Dr. Qing Zhang 章青
Chief Physician
Medical Oncology, Shanghai Proton and Heavy Ion Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy and comprehensive treatment for lung cancer, prostate cancer, and gastric cancer.
Dr. Zhang is a Chief Physician with over ten years of clinical radiotherapy experience. Training includes further study at the National University Cancer Centre Singapore and Fudan University Shanghai Cancer Center. Dr. Zhang has published multiple papers in national journals and explores techniques such as 3D conformal radiotherapy and intensity-modulated radiotherapy. Experience includes managing radiotherapy complications and preventing side effects.
Professional roles
- Member, Radiation Therapy Professional Committee, China Anti-Cancer Association
- Member, Shanghai Branch of Tumor Radiotherapy, Chinese Medical Association
Name order: in Chinese the family name comes first (Zhang Qing). Papers usually list the name as Qing Zhang or Zhang Q.
Selected publications
48 papers on PubMed matched by name and affiliation; 15 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Cancer, 2026 (senior author): Carbon ion radiotherapy for unresectable primary or recurrent soft tissue sarcomas: long-term outcomes based on the local effect model. PubMed 42243703
- Phys Med Biol, 2025 (senior author): Machine learning-enhanced normal tissue complication probability modeling for late sciatic nerve toxicity prediction in carbon-ion radiotherapy: model development and clinical validation. PubMed 41061729
- Adv Radiat Oncol, 2024 (senior author): Intensity Modulated Carbon Ion Radiation Therapy Using Pencil Beam Scanning Technology for Patients With Unresectable Sacrococcygeal Chordoma. PubMed 39410957
- Cancer Med, 2024 (senior author): Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice. PubMed 38379323
- Front Endocrinol (Lausanne), 2023 (senior author): The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer. PubMed 38027094
- Front Endocrinol (Lausanne), 2023 (senior author): Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics. PubMed 38027108
- J Cancer Res Clin Oncol, 2023 (senior author): Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer. PubMed 36138265
- Radiat Oncol, 2023 (senior author): A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose. PubMed 36959653
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion